Inventor · disambiguated record
Natalie Grinshtein
Also filed as: GRINSHTEIN NATALIE
1 granted patent·10 pending applications·0 citations·filing 2019–2023
14Inventor score
Top patents by PatentIndex Score
11 records- 0168US11446401B2Actinium-225 and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·0 cites·1 claims
- 0268US2023270895A1Radioimmunoconjugates and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0363US2021290789A1Radioimmunoconjugates and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0454US2025121104A1Egfr-cmet-targeted compounds and uses thereofFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0553US2024408249A1Egfrviii-targeted compounds and uses thereofNAT RES COUNCIL CANADA·Filed 2022·Application pending·0 cites
- 0651US2024285818A1Radioimmunoconjugates and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0745US2023091468A1Sustained immunotherapyFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0844US2025114488A1Psma-targeted radiopharmaceuticals and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0943US2025099633A1Ntsr1-targeted radiopharmaceuticals and checkpoint inhibitor combination therapyFUSION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1042US2023201384A1Fgfr3-targeted radioimmunoconjugates and uses thereofFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1140US2024139353A1Methods of treating cancerFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Natalie Grinshtein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →